Table 4.
Diagnostic performance of each USE methods.
| Method | Studies,n | Benign,n | Malignant,n | Sens, %(CI, %)(I-square, %) | Spec, %(CI, %)(I-square, %) | PLR (CI) | NLR (CI) | AUC (CI, %) |
|---|---|---|---|---|---|---|---|---|
| Qualitative USE | 26 | 4,635 | 2,640 | 84 (83–85) (91.1) |
81 (80–82) (95.5) |
4.7 (3.5–6.3) |
0.24 (0.17–0.34) |
89.0 (86.8–91.2) |
| Semi-quantitative USE | 22 | 3,801 | 1,889 | 83 (81–84) (83.3) |
80 (79–82) (96.7) |
6.5 (4.2–10.1) |
0.19 (0.13–0.27) |
92.9 (91.0–94.7) |
| Quantitative USE | 32 | 4,236 | 2,507 | 78 (76–79) (58.6) |
81 (80–82) (89.5) |
4.4 (3.6–5.5) |
0.28 (0.24–0.33) |
87.0 (85.7–88.2) |
USE, Ultrasound Elastography.